Bufogenin or resibufogenin
- Level
- Commodity
- Parent
- 51121900
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51121915This classification denotes an enzyme inhibitor with the molecular formula C24H32O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3K654P2M4J, chemically known as 14,15beta-epoxy-3beta-hydroxy-5beta-bufa-20,22-dienolide but generally known as bufogenin, which bears US NIH Compound Identifier 10063. European Medicines Agency schedules Bufogenin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05964MIG. The term BUFOGENIN is an International Non-Proprietary Name. BUFOGENIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Bufogenin or resibufogenin bears US NLM identifiers UMLS ID C0054208 and NCI Concept Code C77829. SMILES: CC12CCC(CC1CCC3C2CCC4(C35C(O5)CC4C6=COC(=O)C=C6)C)O.
Same parent
Under 51121900 · 19Activities that produce or sell this
KBLI · 8Inherited from family 51120000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.